SG11202001937TA - Method for producing influenza ha split vaccine - Google Patents

Method for producing influenza ha split vaccine

Info

Publication number
SG11202001937TA
SG11202001937TA SG11202001937TA SG11202001937TA SG11202001937TA SG 11202001937T A SG11202001937T A SG 11202001937TA SG 11202001937T A SG11202001937T A SG 11202001937TA SG 11202001937T A SG11202001937T A SG 11202001937TA SG 11202001937T A SG11202001937T A SG 11202001937TA
Authority
SG
Singapore
Prior art keywords
split vaccine
producing influenza
influenza
producing
vaccine
Prior art date
Application number
SG11202001937TA
Other languages
English (en)
Inventor
Yoshimasa Takahashi
Yu Adachi
Manabu Ato
Original Assignee
Japan Health Sciences Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Health Sciences Found filed Critical Japan Health Sciences Found
Priority claimed from PCT/JP2018/032537 external-priority patent/WO2019045090A1/ja
Publication of SG11202001937TA publication Critical patent/SG11202001937TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202001937TA 2017-09-04 2018-09-03 Method for producing influenza ha split vaccine SG11202001937TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017169230 2017-09-04
JP2018137952A JP7403733B2 (ja) 2017-09-04 2018-07-23 インフルエンザｈａスプリットワクチンの製造方法
PCT/JP2018/032537 WO2019045090A1 (ja) 2017-09-04 2018-09-03 インフルエンザｈａスプリットワクチンの製造方法

Publications (1)

Publication Number Publication Date
SG11202001937TA true SG11202001937TA (en) 2020-04-29

Family

ID=65815411

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001937TA SG11202001937TA (en) 2017-09-04 2018-09-03 Method for producing influenza ha split vaccine

Country Status (10)

Country Link
US (1) US11732031B2 (zh)
EP (1) EP3679948A4 (zh)
JP (1) JP7403733B2 (zh)
KR (1) KR20200047629A (zh)
CN (1) CN111372605A (zh)
AU (1) AU2018325899B2 (zh)
CA (1) CA3074581A1 (zh)
EA (1) EA202090587A1 (zh)
PH (1) PH12020500414A1 (zh)
SG (1) SG11202001937TA (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7403733B2 (ja) 2017-09-04 2023-12-25 国立感染症研究所長 インフルエンザｈａスプリットワクチンの製造方法
KR20210034614A (ko) 2018-07-23 2021-03-30 국립감염증연구소장이 대표하는 일본국 인플루엔자 백신을 포함하는 조성물
CA3132578A1 (en) * 2019-03-04 2020-09-10 Japan As Represented By Director General Of National Institute Of Infectious Diseases Method for producing influenza ha split vaccine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054481A2 (en) 2006-03-24 2008-05-08 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Improved inactivated influenza virus compositions
EP2138497A4 (en) 2007-03-20 2012-01-04 Dainippon Sumitomo Pharma Co NEW ADENINE CONNECTION
MX2011000768A (es) 2008-07-25 2011-10-05 Inst Research In Biomedicine Anticuerpos neutralizantes del virus anti-influenza a y usos de los mismos.
WO2010047509A2 (ko) 2008-10-24 2010-04-29 아주대학교 산학협력단 친화도와 안정성이 향상된 항 ｄｒ5 항체, 및 이를 포함하는 암 예방 또는 치료용 조성물
CN101524538A (zh) * 2009-03-26 2009-09-09 成都康华生物制品有限公司 一种流感-大流行流感二价联合疫苗及其制备方法
MX338758B (es) 2010-03-08 2016-04-29 Celltrion Inc Anticuerpos monoclonales humanos, derivados de celulas b humanas, y que tienen actividad neutralizante contra el virus de la influenza a.
US9708373B2 (en) 2010-03-30 2017-07-18 Icahn School Of Medicine At Mount Sinai Influenza virus vaccine and uses thereof
BR112013025254A2 (pt) 2011-04-21 2016-09-06 Baxter Internat Inc E Baxter Healthcare S A método para isolar um antígeno de uma composição de vacina
US20150098966A1 (en) 2012-05-16 2015-04-09 Kj Biosciences Llc Influenza vaccines
KR20140118682A (ko) 2013-03-29 2014-10-08 (주)셀트리온 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물
SG11201701279VA (en) * 2014-08-18 2017-03-30 Sanofi Pasteur Inc Alkylated influenza vaccines
IL253187B (en) 2014-12-31 2022-07-01 Us Health New vaccines based on multivalent nanoparticles
JP7403733B2 (ja) 2017-09-04 2023-12-25 国立感染症研究所長 インフルエンザｈａスプリットワクチンの製造方法
KR20210034614A (ko) 2018-07-23 2021-03-30 국립감염증연구소장이 대표하는 일본국 인플루엔자 백신을 포함하는 조성물

Also Published As

Publication number Publication date
KR20200047629A (ko) 2020-05-07
PH12020500414A1 (en) 2021-03-08
CA3074581A1 (en) 2019-03-07
AU2018325899B2 (en) 2023-04-20
US20190345231A1 (en) 2019-11-14
CN111372605A (zh) 2020-07-03
EA202090587A1 (ru) 2020-08-24
EP3679948A4 (en) 2021-04-28
JP7403733B2 (ja) 2023-12-25
AU2018325899A1 (en) 2020-04-09
EP3679948A1 (en) 2020-07-15
US11732031B2 (en) 2023-08-22
JP2019043937A (ja) 2019-03-22

Similar Documents

Publication Publication Date Title
HK1248759A1 (zh) 用於產生製備疫苗的病毒的方法
EP3538146A4 (en) INFLUENZA VACCINE
EP3506939A4 (en) METHOD FOR PRODUCING A VIRUS FOR THE VACCINE PRODUCTION
SG10201912648WA (en) Method for producing cyclododecanone
EP3333266C0 (en) SELENOEIN PRODUCTION PROCESS
IL266044B (en) Method for the production of 3-alkylsulfanyl-2-chloro-n-(1-alkyl-h1-tetrazol-5-yl)-4-trifluoromethyl-benzamides
EP3666729C0 (en) PROCESS FOR THE PRODUCTION OF NANO-SULFUR
HK1259146A1 (zh) 用於流感疫苗接種的方法和組合物
EP3045444A4 (en) Method of preparing vanillin
ZA201608778B (en) Method for preparing dimethyl disulphide
HK1249098A1 (zh) 用於生產氟美他酚的方法
SG11202001937TA (en) Method for producing influenza ha split vaccine
PT3252143T (pt) Método de produção de um gel contendo lisado de plaquetas
SG11201709420PA (en) Method for producing soi wafer
HK1256031A1 (zh) 新的4-苯並偶氮寧衍生物的製造方法
HUE051783T2 (hu) Eljárás immunogén hemagglutinin mennyiségi meghatározására
GB201714060D0 (en) Method for preparing itraconazole preparation
EP3562498A4 (en) INFLUENZA Vaccines
IL249500A0 (en) Reno vaccine system of influenza vaccine component
EP3423090C0 (en) NOVEL INFLUENZA ANTIGENS
ZA201903463B (en) Method for preparing hexadecahydropyrene
IL285984A (en) A method for producing a split influenza component
IL255093A0 (en) A method for the production of levoglucosenon
LT3655459T (lt) Poliesterių gamybos būdas
PL3511315T3 (pl) Sposób wytwarzania n-metylo-para-anizydyny